We proposed that the expression indexes of TB-specific CD4+ T cell activation markers CD25, CD69, and CD134 could be promising new tools for the diagnosis of ATB, with the coexpression of CD25 and CD134 optimal for differential diagnosis. The gene discussed is TNFRSF4; the disease is tuberculosis.